你即將離開本站

並前往https://cardiab.biomedcentral.com/articles/10.1186/s12933-020-01163-9

Renoprotection with SGLT2 inhibitors in type 2 diabetes over ...

DAPA -CKD was the first phase 3 trial to investigate the safety and renal outcomes of an SGLT2 inhibitor in people with CKD, both with and ...

確定！ 回上一頁

查詢 「DAPA-CKD trial」的人也找了：

  1. dapa-ckd trial ppt
    2.
  2. Dapagliflozin hemodialysis
    3.
  3. EMPA CKD
    4.
  4. dapa ckd中文
    5.
  5. CREDENCE trial
    6.
  6. Dapa ckd trial wiki
    7.
  7. Empagliflozin CKD
    8.
  8. DECLARE-TIMI 58
    9.